Patent · US Expired

Methods and compositions for primary and secondary prevention of autoimmune diabetes

US5665387A · kind A · utility

13Cited by

4References

19Claims

0Family size

Assignee

K.U. Leuven Research & Development · BE

Inventors

Chantal Mathieu · Buizingen, BE
Mark Waer · Heverlee, BE
Roger Bouillon · Herent, BE

Key dates

Filing date	Sep 1, 1994
Grant date	Sep 9, 1997
Priority date	—
Expiry date	Sep 1, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for modulating the immune system by administering one or more vitamin D (analogues) to a subject in need of immune therapy, which method may (but need not) include simultaneous treatment with a second immune system modulating active agent. Preferably, the treatment method is used to induce primary or secondary prevention of type I diabetes in a subject susceptible to type I diabetes. Administration of the vitamin D (analogues) is enteral or parenteral.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.